providing citation data for Economics since 2001
[Raw data] [Main indicators] [Most cited papers] [cites used to compute the impact factor] [Recent citations ][documents published in EconPapers] [
Keep updated about new citations] [Missing citations? Add them now] [Incorrect content? Let us know]
Raw data: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IF: Impact Factor: C2Y / D2Y AIF: Average Impact Factor for series in RePEc in year y DOC: Number of documents published in year y CDO: Cumulative number of documents published until year y CCU: Cumulative number of citations to papers published until year y CIF: Cumulative impact factor CIT: Number of citations to papers published in year y D2Y: Number of articles published in y-1 plus y-2 C2Y: Cites in y to articles published in y-1 plus y-2 %SC: Percentage of selft citations in y to articles published in y-1 plus y-2 CiY: Cites in year y to documents published in year y II: Immediacy Index: CiY / Documents. AII: Average Immediacy Index for series in RePEc in year y |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Most cited documents in this series:
| Year | Title | Cited |
|---|---|---|
| 2011 | Effects of Reference Pricing in Pharmaceutical Markets. (2011). Galizzi, Matteo ; Miraldo, Marisa ; Ghislandi, Simone . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers || Download paper | 3 |
| 2006 | The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003. (2006). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:3:p:5-25. Full description at Econpapers || Download paper | 3 |
| 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 3 |
| 2006 | The Impact of Therapeutic Reference Pricing on Innovation in Cardiovascular Medicine. (2006). SHERIDAN, DESMOND ; ATTRIDGE, JIM. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:2:p:35-54. Full description at Econpapers || Download paper | 2 |
| 1998 | Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma. (1998). Doorslaer, Eddy ; Molken, Maureen ; Till, M.. In: PharmacoEconomics. RePEc:spr:pharme:v:14:y:1998:i:6:p:671-684. Full description at Econpapers || Download paper | 1 |
| 2006 | Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996â2003. (2006). Liu, Chien-Hsiang ; Lee, Yue-Chune ; Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902. Full description at Econpapers || Download paper | 1 |
| 2006 | Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries. (2006). Brezin, Antoine ; Mimaud, Viviane ; Lopatriello, Stefania ; Hieke, Klaus ; Hutchinson, Julia ; Berdeaux, Gilles ; Lafuma, Antoine . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:2:p:193-205. Full description at Econpapers || Download paper | 1 |
| 2008 | Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Koss, Catherine ; Frank, Richard ; Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616. Full description at Econpapers || Download paper | 1 |
| 2006 | The Value of Thinly Spread QALYs. (2006). Mortimer, Duncan . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:845-853. Full description at Econpapers || Download paper | 1 |
| 2010 | The State of Health Economic Evaluation Research in Nigeria. (2010). Oladapo, Abiola ; Khoza, Star ; Gavaza, Paul ; Rascati, Karen . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:7:p:539-553. Full description at Econpapers || Download paper | 1 |
| 2006 | Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain. (2006). Bagust, Adrian ; Escolano, Isabel Perez ; Paris, Gonzalo ; Ampudia-Blasco, F. ; alvarez, Belen Martinez-Lage ; Shearer, Arran . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:1:p:49-59. Full description at Econpapers || Download paper | 1 |
| 2008 | Cost-Effectiveness Analyses of Hepatitis A Vaccine. (2008). Anonychuk, Andrea ; Gilca, Vladimir ; Krahn, Murray ; Woo, Gloria ; Bauch, Chris ; Duval, Bernard ; Pham, Ba ; John-Baptiste, Ava ; Tricco, Andrea . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:1:p:17-32. Full description at Econpapers || Download paper | 1 |
| 2010 | Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?. (2010). Salkeld, Glenn ; Kelly, Patrick ; Stockler, Martin ; Chim, Lesley . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:6:p:463-475. Full description at Econpapers || Download paper | 1 |
| 2006 | Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies. (2006). Birks, Stuart . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1273-1274. Full description at Econpapers || Download paper | 1 |
| 2007 | Measuring Preferences for Cost-Utility Analysis. (2007). Tosteson, Anna ; McDonough, Christine . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:2:p:93-106. Full description at Econpapers || Download paper | 1 |
| 2006 | The Impact of Incremental Innovation in Biopharmaceuticals. (2006). Cockburn, Iain ; Berndt, Ernst ; Grepin, Karen . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:2:p:69-86. Full description at Econpapers || Download paper | 1 |
| 2010 | An Analysis of NICEâs âRestrictedâ (or âOptimizedâ) Decisions. (2010). Devlin, Nancy ; ONeill, Phill . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:11:p:987-993. Full description at Econpapers || Download paper | 1 |
| 2005 | Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease. (2005). Briggs, Andrew ; Grossman, Ronald ; Spencer, Michael ; Rance, Laureen . In: PharmacoEconomics. RePEc:spr:pharme:v:23:y:2005:i:6:p:619-637. Full description at Econpapers || Download paper | 1 |
| 2007 | Economic Evidence at the Local Level. (2007). Viney, Rosalie ; Haas, Marion ; Hall, Jane ; Gallego, Gisselle ; Ward, Robyn ; Gool, Kees . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:12:p:1055-1062. Full description at Econpapers || Download paper | 1 |
| 2012 | Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands. (2012). Delwel, Gepke ; Hoomans, Ties ; Roer, Nicole ; Severens, Johan . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:219-227. Full description at Econpapers || Download paper | 1 |
Citing documents used to compute impact factor 2:
| Year | Title | See |
|---|---|---|
| 2012 | A systematic review of coverage decision-making on health technologiesâEvidence from the real world. (2012). Fischer, Katharina. In: Health Policy. RePEc:eee:hepoli:v:107:y:2012:i:2:p:218-230. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | Assessing the Quality of Pharmacoeconomic Studies in India. (2012). Desai, Pooja ; Rascati, Karen ; Chandwani, Hitesh . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:9:p:749-762. Full description at Econpapers || Download paper | [Citation Analysis] |
Recent citations received in: 2011
| Year | Title | See |
|---|---|---|
| 2011 | Competition and the Reference Pricing Scheme for pharmaceuticals. (2011). Ghislandi, Simone . In: Journal of Health Economics. RePEc:eee:jhecon:v:30:y:2011:i:6:p:1137-1149. Full description at Econpapers || Download paper | [Citation Analysis] |
Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.
Source data used to compute the impact factor of RePEc series.